u 89678 has been researched along with Subarachnoid Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleishaker, JC; Hulst, LK; Peters, GR | 1 |
| Hall, ED; Scherch, HM; Smith, SL | 1 |
2 other study(ies) available for u 89678 and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteers.
Topics: Adult; Chromatography, High Pressure Liquid; Craniocerebral Trauma; Drug Tolerance; Half-Life; Humans; Infusions, Intravenous; Lipid Peroxides; Male; Middle Aged; Pregnatrienes; Subarachnoid Hemorrhage | 1994 |
Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury.
Topics: Animals; Antioxidants; Blood-Brain Barrier; Cells, Cultured; Lipid Peroxides; Male; Mice; Mice, Inbred Strains; Neurons; Neuroprotective Agents; Pregnatrienes; Rats; Rats, Sprague-Dawley; Spinal Cord; Subarachnoid Hemorrhage | 1996 |